|
|
 |
|
Viewing report
|
|
|
|
Advantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China
Frost & Sullivan, July 2005
International Pharmaceutical Companies Develop Research Base in India and China
Beleaguered by ever-increasing cost pressures, shorter product life cycles and various regulatory challenges in the West, the pharmaceutical industry is turning to opportunities in low-cost Asian countries such as India and China. Alliances with local companies, contractual outsourcing arrangements and establishment of local subsidiaries enable these enterprises to access openings in both countries, especially in the area of pharmaceutical research and development (R&D).
This service analyses the advantages and disadvantages of pharma R&D outsourcing to India and China. The study discusses the various trends and opportunities in each country while providing in-depth market share analysis, forecasts, drivers, restraints, and revenue forecasts. It also enables companies to align their positioning strategies to benefit from the changing environment and obtain maximum return on investment.
Customers who bought this item also bought
Pharmaceutical Outsourcing Strategies: Market Expansion, Offshoring and Strategic Management in the CRO and CMO Marketplace
Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US
Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market
Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs
The CRO Market Outlook to 2016
The CRO Market Outlook: Emerging Markets, Leading Players and Future Trends
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials
Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities
Outsourcing Clinical Trials: A Global Analytical Guide and Comparative Analysis of International Destinations, with Location Attractiveness Index
Global Clinical Trial Market (2007 - 2010) (Key Therapeutic Categories, Country Wise Metrics & Regulatory Approval Framework)
|
|
|
|
